Immunology and Microbiology
Epithelial Mesenchymal Transition
100%
down Regulation
100%
Serine
100%
Promoter Region
66%
Cancer Cell
66%
Disease Free Survival
66%
mRNA Expression Level
33%
Upregulation
33%
Cell Invasion
33%
Recurrence Free Survival
33%
Cell Motility
33%
Cell Migration
33%
Methylation
33%
Cancer Staging
33%
Histone
33%
Keyphrases
Breast Cancer
100%
Poor Survival
100%
Serine Protease
100%
HTRA1
100%
Epithelial-to-mesenchymal Transition
27%
Patient Outcomes
18%
Disease-free Survival
18%
Validation Set
9%
Methylation
9%
MRNA Level
9%
MRNA Expression
9%
Clinical Parameters
9%
Multivariable
9%
Patient Survival
9%
Impact on Patients
9%
Breast Cancer Patients
9%
Breast Tumor
9%
MCF-7
9%
Prognostic Relevance
9%
Promoter Methylation
9%
Cox Proportional Hazards Model
9%
Cell Motility
9%
Mesenchymal Cells
9%
Small Molecule Inhibitors
9%
Node-positive Breast Cancer
9%
Breast Cancer Cells
9%
Histone Deacetylase Inhibitor (HDACi)
9%
Cancer Invasion
9%
Promoter Analysis
9%
HTRA1 Gene
9%
Demethylating Agents
9%
Predicting Diseases
9%
Tumor Stage
9%
Validation Cohort
9%
Node-positive
9%
Factors Predicting
9%
Relapse-free Survival
9%
MDA-MB-231 Cells
9%
Medicine and Dentistry
down Regulation
100%
Breast Cancer
100%
Serine Protease HTRA1
100%
Mesenchymal-Epithelial Transition
37%
Promoter Region
25%
Cancer Cell
25%
Disease Free Survival
25%
Messenger RNA
25%
Cancer Staging
12%
Upregulation
12%
Breast Tumor
12%
Cell Invasion
12%
Proportional Hazards Model
12%
Recurrence Free Survival
12%
Histone Deacetylase Inhibitor
12%
Serine Proteinase
12%
MCF-7
12%
Cell Motility
12%
Cell Migration
12%
Methylation
12%
Biochemistry, Genetics and Molecular Biology
HTRA1
100%
down Regulation
100%
Serine Protease
100%
Mesenchymal-Epithelial Transition
25%
Cancer Cell
16%
Promoter Region
16%
Disease Free Survival
16%
Methylation
8%
Cell Migration
8%
Small Molecule
8%
Demethylating Agent
8%
Upregulation
8%
Cell Invasion
8%
Cell Motility
8%
mRNA Expression Level
8%
Recurrence Free Survival
8%
Cancer Staging
8%
Histone Deacetylase
8%
Messenger RNA
8%